1. | hockeynutz4 | |
2. | er09 | |
3. | bkmetzfrontierco | |
4. | adelaydpec9 | |
5. | johnknickerb |
1. | hockeynutz4 | |
2. | er09 | |
3. | bkmetzfrontierco | |
4. | adelaydpec9 | |
5. | johnknickerb |
1. | johnknickerb 02/07/2018 FDA approves Biktarvy for treatment of HIV-1 |
2. | Fibonacci 10/18/2017 price set at $373,000 |
3. | bkmetzfrontierco 01/31/2018 Finbox.io points out that Gilead shares are ultra cheap compared to their peers right now. |
4. | er09 02/08/2018 You holding this? |
5. | er09 09/28/2017 $GILD I think this is perfect opportunity for people like me who doesnt have it covered.. |
6. | hockeynutz4 02/07/2018 Nice to see them taking action |
7. | terrynkids 02/08/2018 Gilead Sciences' HIV Franchise Is Poised to Recapture Share, Says Senior Analyst Phil Nadeau |
8. | hockeynutz4 01/26/2018 Jefferies raises to buy |
9. | er09 02/22/2018 Long news? - J.P. Morgan Weighs in on Sangamo Therapeutics Inc's (SGMO) Collaboration with Kite |
10. | er09 10/18/2017 Gilead Gets FDA Approval for New Cancer Therapy |